Placemark Investments, Inc. - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Placemark Investments, Inc. ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$2,930,000
+81.9%
47,423
+14.4%
0.05%
+73.3%
Q3 2014$1,611,000
+31.3%
41,463
+16.6%
0.03%
+36.4%
Q2 2014$1,227,000
-29.3%
35,561
-11.5%
0.02%
-33.3%
Q1 2014$1,735,000
+71.4%
40,175
+57.8%
0.03%
+94.1%
Q4 2013$1,012,000
+14.2%
25,461
+8.0%
0.02%0.0%
Q3 2013$886,000
+75.4%
23,565
+25.4%
0.02%
+54.5%
Q2 2013$505,00018,7850.01%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,417,548$255,675,00013.66%
HWG Holdings LP 339,799$13,538,0008.73%
DOWLING & YAHNKE LLC 675,798$26,924,0003.78%
GARRISON BRADFORD & ASSOCIATES INC 99,300$3,956,0003.74%
WILLIAM HARRIS INVESTORS INC 283,834$11,308,0003.35%
SECTORAL ASSET MANAGEMENT INC 1,222,401$48,700,0002.10%
AVALON CAPITAL MANAGEMENT 49,999$1,992,0001.68%
PINNACLE ASSOCIATES LTD 2,016,369$80,332,0001.57%
PERKINS CAPITAL MANAGEMENT INC 48,515$1,933,0001.30%
NCM Capital Advisers, Inc. 31,100$1,239,0001.28%
View complete list of ISIS PHARMACEUTICALS INC shareholders